These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6842121)

  • 21. Regulation of thyrotrophin secretion by negative feedback of tri-iodothyronine on the hypothalamus.
    Belchetz PE; Gredley G; Bird D; Himsworth RL
    J Endocrinol; 1978 Mar; 76(3):439-48. PubMed ID: 416161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurotensin in the rat anterior pituitary gland: effects of endocrinological manipulations.
    Goedert M; Lightman SL; Emson PC
    Brain Res; 1984 May; 299(1):160-3. PubMed ID: 6722564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurotensin stimulation of prolactin secretion in vitro.
    Enjalbert A; Arancibia S; Priam M; Bluet-Pajot MT; Kordon C
    Neuroendocrinology; 1982 Feb; 34(2):95-8. PubMed ID: 7070589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of inhibitory effects of 3,5,3'-triiodothyronine (T3), thyroxine (T4), 3,3,',5'-triiodothyronine (rT3), and 3,3'-diiodothyronine (T2) on thyrotropin-releasing hormone-induced release of thyrotropin in the rat in vitro.
    Chopra IJ; Carlson HE; Solomon DH
    Endocrinology; 1978 Aug; 103(2):393-402. PubMed ID: 105890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interactions of dopamine and neurotensin on calcium fluxes and prolactin release in normal rat pituitary cells.
    Login IS; Kuan SI; Judd AM; MacLeod RM
    Endocrinology; 1990 Oct; 127(4):1948-55. PubMed ID: 1698150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thyroid status affects the regulation of prolactin mRNA accumulation by tri-iodothyronine and thyrotrophin-releasing hormone in cultured rat anterior pituitary cells.
    Wood DF; Docherty K; Ramsden DB; Shennan KI; Sheppard MC
    J Endocrinol; 1987 Dec; 115(3):497-503. PubMed ID: 3127514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of acute and chronic treatment with triiodothyronine and thyroxine on the hypothalamic and telencephalic catecholamine nerve terminal systems of the hypophysectomized male rat. Chronic treatment modulates catecholamine utilization in discrete catecholamine nerve terminal systems.
    Andersson K; Eneroth P
    Neuroendocrinology; 1985 May; 40(5):398-408. PubMed ID: 4010888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for neurotensin autoreceptors and relationship of neurotensin and its receptors with tyrosine hydroxylase-positive neurons in rat primary hypothalamic cultures.
    Bachelet CM; Scarcériaux V; Rostène W; Pélaprat D
    Eur J Neurosci; 1997 Jul; 9(7):1483-7. PubMed ID: 9240405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peptidases involved in the catabolism of neurotensin: inhibitor studies using superfused rat hypothalamic slices.
    McDermott JR; Virmani MA; Turner JD; Kidd AM
    Peptides; 1986; 7(2):225-30. PubMed ID: 3526299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opiate-mediated inhibition of the release of cholecystokinin and substance P, but not neurotensin from cat hypothalamic slices.
    Micevych PE; Yaksh TL; Go VL
    Brain Res; 1982 Nov; 250(2):283-9. PubMed ID: 6184121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of methamphetamine on neurotensin concentrations in rat brain regions.
    Letter AA; Merchant K; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1987 May; 241(2):443-7. PubMed ID: 3572804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of alterations in the pituitary-thyroid axis on hypothalamic content and in vitro release of somatostatin-like immunoreactivity.
    Berelowitz M; Maeda K; Harris S; Frohman LA
    Endocrinology; 1980 Jul; 107(1):24-9. PubMed ID: 6103803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postnatal developmental pattern of thyrotrophin releasing hormone-degrading activity in rat plasma, hypothalamus and liver: role of tri-iodothyronine.
    Aratan-Spire S; Moilanen K; Czernichow P
    J Endocrinol; 1983 Jun; 97(3):409-18. PubMed ID: 6408215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypothyroidism of hypothalamic origin in pyridoxine-deficient rats.
    Dakshinamurti K; Paulose CS; Vriend J
    J Endocrinol; 1986 Jun; 109(3):345-9. PubMed ID: 3090182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The regulation of neuropeptide expression in rat anterior pituitary following chronic manipulation of estrogen status: a comparison between substance P, neuropeptide Y, neurotensin, and vasoactive intestinal peptide.
    O'Halloran DJ; Jones PM; Ghatei MA; Domin J; Bloom SR
    Endocrinology; 1990 Sep; 127(3):1463-9. PubMed ID: 1696887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopamine inhibition of neurotensin-induced increase in Ca2+ influx into rat pituitary cells.
    Memo M; Carboni E; Trabucchi M; Carruba MO; Spano PF
    Brain Res; 1985 Nov; 347(2):253-7. PubMed ID: 2415214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Triiodo-L-thyronine enhances TRH-induced TSH release from perifused rat pituitaries and intracellular Ca2+ levels from dispersed pituitary cells.
    Roussel JP; Grazzini E; Zumbihl R; Rodriguez E; Astier H
    Eur J Pharmacol; 1995 Apr; 289(2):205-15. PubMed ID: 7621893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coexistence of dopamine and neurotensin in hypothalamic arcuate and periventricular neurons.
    Ibata Y; Fukui K; Okamura H; Kawakami T; Tanaka M; Obata HL; Tsuto T; Terubayashi H; Yanaihara C; Yanaihara N
    Brain Res; 1983 Jun; 269(1):177-9. PubMed ID: 6347339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of oestradiol, hypothalamic extracts and luteinizing hormone releasing hormone on rat anterior pituitary gland gonadotrophin release in vitro before and after the preovulatory luteinizing hormone surge at pro-oestrus.
    Elias KA; Blake CA
    J Endocrinol; 1981 Sep; 90(3):345-54. PubMed ID: 6792313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Release of beta-endorphin-immunoreactivity from rat pituitary and hypothalamus in vitro: effects of isoproterenol, dopamine, corticotropin-releasing factor and arginine8-vasopressin.
    Sweep CG; Wiegant VM
    Biochem Biophys Res Commun; 1989 May; 161(1):221-8. PubMed ID: 2525039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.